2026-01-29 - Analysis Report
**Company Overview**
Northrop Grumman Corporation is a leading global aerospace and defense technology company.

**Return Rate Comparison**
| Ticker | Cumulative Return |
|--------|-------------------|
| NOC    | 123.73%           |
| VOO    | 128.51%           |
| Divergence  | -8.10           |
| Relative Divergence  | 47.90%           |

The cumulative return of NOC is lower than that of VOO, indicating a divergence of -8.10%. However, the relative divergence is 47.90%, indicating that NOC's performance is at the upper end of the historical fluctuation range.

**Alpha and Beta Analysis**
| Period | CAGR | MDD  | Alpha | Beta | Cap(B) |
|--------|------|------|-------|------|-------|
| 2016-2018 | 0.0% | 24.8% | -9.0% | 0.7 | 35.0B |
| 2017-2019 | 25.0% | 24.8% | 0.0% | 0.7 | 49.1B |
| 2018-2020 | -32.0% | 27.2% | -56.0% | 0.8 | 43.5B |
| 2019-2021 | 32.0% | 27.2% | -32.0% | 0.7 | 55.2B |
| 2020-2022 | 45.0% | 25.9% | 41.0% | 0.6 | 77.9B |
| 2021-2023 | 50.0% | 19.7% | 32.0% | 0.3 | 66.8B |
| 2022-2024 | 19.0% | 19.7% | -10.0% | 0.3 | 67.0B |
| 2023-2025 | 27.0% | 18.4% | -48.0% | 0.1 | 81.4B |

The company's Alpha values indicate mixed results, with some periods showing positive returns while others show negative returns. The Beta values indicate that the company's stock is highly correlated with the market, with most Beta values over 0.7.

**Recent Stock Price Fluctuations**
| Metric | Value |
|--------|-------|
| Close  | $689.13 |
| Last-market | $689.13 | 
| Change | 1.53 |
| 5-day SMA | $674.45|
| 20-day SMA | $633.11|
| 60-day SMA | $588.21|

The 5-day SMA is higher than the current close price, indicating a potential short-term trend reversal. The 20-day and 60-day SMAs are lower, indicating a longer-term bearish trend.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis**
| Indicator | Value |
|-----------|-------|
| RSI    | 84.41 |
| PPO    | 0.54  |
| MRI    | 0.70  |
| Expected Return (%) | -13.00% |

The RSI value is high, indicating overbought conditions. The PPO value is low, indicating a potential buy signal. The MRI value indicates a medium risk investment. The expected return is negative, indicating a potential long-term decline.

**Recent News and Significant Events**
- Northrop Grumman Flashed a Buy Signalâ€”And the Market Backed It Up - MarketBeat
- Northrop Earnings Beat Estimates. Why the Stock Is Down. - Barron's
- Northrop Grumman tops estimates as stock rebounds after Trump order (NOC:NYSE) - Seeking Alpha
- New Analyst Forecast: $NOC Given $815 Price Target - Quiver Quantitative
- RTX, Northrop Grumman Rise In Defense-Heavy Earnings Week - Investor's Business Daily
- Citigroup Raises Price Target for Northrop Grumman (NOC) to $781 - GuruFocus

These news headlines indicate a positive trend for the company, with analysts flashing a buy signal and increasing their price targets.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 21
- Target Price (avg/high/low): 699.25 / 781.00 / 587.22

Most analysts recommend a buy on the stock, with a mean rating of 2.17. The target price is $699.25, with some analysts expecting a higher price of $781.00.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-21 | 7.69 | 10.42 B$ |
| 2025-07-22 | 8.17 | 10.35 B$ |
| 2025-04-22 | 3.33 | 9.47 B$ |
| 2024-10-24 | 7.02 | 10.00 B$ |

The company's EPS and revenue have been increasing over the past year, indicating a positive earnings trend.

**Revenue and Profitability Analysis**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-12-31 | $11.71B | 19.60% |
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |

The company's revenue and profit margin have been increasing over the past year, indicating improved financial performance.

**Capital and Profitability Analysis**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-12-31 | $16.67B | 8.56% |
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |

The company's equity and ROE have been increasing over the past year, indicating improved capital efficiency and profitability.

**Comprehensive Analysis**
The company's stock has been performing well over the past year, with a cumulative return of 123.73%. The recent news and significant events indicate a positive trend, with analysts flashing a buy signal and increasing their price targets. The earnings analysis indicates a positive earnings trend, with increasing EPS and revenue over the past year. The financial analysis indicates improved financial performance, with increasing revenue and profit margin over the past year. However, the RSI value is high, indicating overbought conditions, and the expected return is negative, indicating a potential long-term decline.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.